[Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information].

Hassani, Yasmine

[Monitoring and evaluation tools for irinotecan and bevacizumab in glioblastoma: from prescription to patient's information]. [electronic resource] - Bulletin du cancer May 2012 - 513-20 p. digital

Publication Type: Journal Article

1769-6917

10.1684/bdc.2012.1573 doi


Antibodies, Monoclonal, Humanized--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bevacizumab
Brain Neoplasms--drug therapy
Camptothecin--administration & dosage
Contraindications
Drug Monitoring--methods
Family
France
General Practice
Glioblastoma--drug therapy
Humans
Irinotecan
Medical Oncology--methods
Off-Label Use
Pamphlets
Patient Education as Topic--methods
Pharmaceutical Services
Pharmacovigilance
Prescription Drugs--economics